2015-05-13 19:12:29 UTC

Dr. Chey Receives AGA's 2015 Distinguished Clinician Award

May 13, 2015

William Chey, MD, received the award during DDW® 2015 in Washington, DC.

AGA has honored William (Bill) D. Chey, MD, with the Distinguished Clinician Award. This award is given to an individual who exemplifies leadership and excellence in the clinical academic practice of gastroenterology. Dr. Chey, of the University of Michigan in Ann Arbor, MI, received the award at Digestive Disease Week® (DDW) 2015 in Washington, DC.

Dr. Chey has built a world-renowned reputation as a talented and skilled clinician in gastroenterology, focusing on functional GI disorders, acid-related disorders and H. pylori infection. Since 1993, Dr. Chey has been the director of the GI Physiology Laboratory at University of Michigan, Ann Arbor, which is one of the most prestigious departments for evaluating functional GI disease and motility disorders. Dr. Chey has the unique ability to identify solutions for gaps in our current care model. This is exemplified by his work co-founding and co-directing the Michigan Bowel Program, which is a multi-disciplinary program that provides breakthrough care to patients with chronic constipation and fecal incontinence. He is also the founder and director of the Center for GI Nutrition and Behavioral Medicine in the division of gastroenterology at the University of Michigan.

Dr. Chey is committed to innovation, co-developing a novel patient-provider portal called “My GI Health,” which allows enhanced and streamlined gathering of patient information and provision of high-quality tailored education. He has also developed and patented a novel disposable, glove-based manometry system, which will allow physicians to make the diagnosis of dyssynergic defecation at the bedside.

Along with his extensive career as a clinician, Dr. Chey conducts valuable research for the field of gastroenterology and has been involved and led many guidelines on the treatment of functional GI disease and H. pylori. Dr. Chey has published more than 300 manuscripts, reviews and book chapters, and is a sought-after invited lecturer, having given innumerable lectures and presentations at international, national and local meetings and during visiting professor programs. His teaching style, which expertly blends his scientific knowledge with an experienced practical approach, resonates with a vast number of clinicians and trainees.

Dr. Chey’s clinical prowess was recently recognized with induction into the “Clinical Excellence Society” of the department of internal medicine at the University of Michigan. He has received the Outstanding Clinician Award from the Dean’s Office at the University of Michigan. Dr. Chey has been listed in Best Doctors in America since 2001, the top 1 percent of U.S. gastroenterologists in US News and World Report in 2012 and 2013, and one of the 160 “Gastroenterologists to Know” in Becker‘s ASC Review.

From 2004 to 2008, Dr. Chey served as vice-chair and chair of the AGA Clinical Practice Section and on the Nominating Committee, as well as on the Abstract Selection Committee for several AGA Institute Council sections. With regard to other medical organizations, he is an active member of the Rome Foundation and on the Rome IV Functional Bowel Disorders Committee. He is currently co-editor-in-chief of the American Journal of Gastroenterology and founding co-editor of Clinical & Translational Gastroenterology. He has served on the editorial boards of both Gastroenterology and Clinical Gastroenterology and Hepatology. Dr. Chey, completed his medical degree in 1986 and his residency in 1989 at the Emory University School of Medicine, Atlanta, GA. After completing his residency, Dr. Chey completed his fellowship in gastroenterology at the University of Michigan, School of Medicine, and thereafter joined the faculty, where he has remained for more than 20 years.

More on Helicobacter pylori Infection

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial

Oct. 22, 2017

This randomized clinical trial with 13 years of follow-up evaluation, designed to provide evidence on the effect of H pylori population screening, showed no significant long-term effect when compared with usual care in this low-prevalence area.

Submucosal Tumor of the Stomach With Drastic, Short-Term Changes in Morphology

Aug. 10, 2017

What caused the lesion in a man diagnosed with a submucosal tumor in the upper gastric corpus, to change to a reddish, semipedunculated tumor with blood oozing on the surface?